Related Experiment Videos
Endoscopic laser ablation of the prostate. A new technique for treating prostate problems
The British Journal of Theatre Nursing : Natnews : the Official Journal of the National Association of Theatre Nurses
|March 1, 1994
Summary
Endoscopic laser ablation of the prostate (ELAP) offers a quicker surgical option for benign prostatic enlargement, with reduced bleeding and shorter hospital stays compared to traditional transurethral resection of the prostate (TURP). Early results show comparable effectiveness to TURP.
Area of Science:
- Urology
- Minimally Invasive Surgery
Background:
- Benign prostatic enlargement (BPE) causes bladder outflow obstruction in many men over 50.
- Transurethral resection of the prostate (TURP) is the standard surgical treatment for BPE.
- TURP has drawbacks including bleeding and longer recovery times.
Purpose of the Study:
- To introduce and evaluate endoscopic laser ablation of the prostate (ELAP) as an alternative to TURP.
- To assess the efficacy and safety of ELAP for treating BPE.
Main Methods:
- ELAP utilizes a side-firing laser fiber passed through a cystoscope to ablate prostate tissue.
- Laser energy heats and shrinks the enlarged prostate gland.
- Procedures are performed under anesthesia, with patients often discharged same or next day.
Main Results:
- ELAP is a quicker procedure than TURP.
- ELAP results in significantly less bleeding compared to TURP.
- Patients undergoing ELAP experience shorter hospital stays and fewer complications.
- Early outcomes of ELAP are comparable to TURP.
Conclusions:
- ELAP is a promising alternative surgical treatment for benign prostatic enlargement.
- ELAP offers advantages over TURP, including reduced bleeding, shorter recovery, and comparable efficacy.
- Further studies may confirm ELAP's long-term benefits and wider adoption.